Analgesics saw one of the highest increases in consumption in Uruguay in current value terms during the review period. One of the reasons for this was the rise in self-medication, which is of concern to the health authorities in the country. Moreover, the increase in sales can also be attributed to the general confidence shown by Uruguayan consumers towards analgesics. Nevertheless, the category is reaching maturity and growth is expected to slow down over the forecast period.
Euromonitor International's Analgesics in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Get a detailed picture of the Analgesics market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market’s major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.